Table 1 Baseline measurements of included patients with COVID-19 according to level of NT-proBNP

Age (year)

61.69 (17.41)

53.68 (17.45)

64.06^a (16.22)

61.31 (19.53)

Gender (F/M)

127/145

22/27

82/95

23/23

ICU admission (yes/no)

138/134

18/31

89/88

31/15^a,b

severity (severe/non-severe)

168/104

22/27

110/67^a

36/10^a,b

Hospital death (yes/no)

80/188

4/44

54/121^a

22/23^a,b

History of HT (yes/no)

136/136

18/31

91/86

27/19

History of CAD (yes/no)

60/212

7/42

37/140

16/30

History of DM (yes/no)

72/200

12/37

48/129

12/34

History of resp (yes/no)

17/255

3/46

12/165

2/44

History of cancer (yes/no)

14/258

4/45

8/169

2/44

History of KD (yes/no)

16/256

2/47

11/166

3/43

History of ARB yes/no

112/160

16/33

74/103

22/24

WBC (10³/µL)

10.38 (5.61)

8.46 (4.8)

10.61 (5.99)

11.55^a (4.34)

CRP (mg/L)

100.61 (115.22)

74.89 (69.57)

108.16 (132.30)

97.47 (65.88)

BUN (mg/dL)

34.85 (30.55)

23.72 (25.03)

34.30 (27.20)

50.46^a,b (42.17)

PCT (ng/mL)

3.28 (11.28)

0.90 (2.54)

2.85 (10.42)

6.79 (16.81)

Creatinine (mg/dL)

1.57 (1.47)

1.11 (1.10)

1.50 (1.14)

2.42^a,b (2.43)

Troponin (positive/negative)

64/205

0/49

25/105^a

39/7^a,b

NT-proBNP (pg/mL)

6362.17 (9013.81)

131.02 (113.99)

3516.54^a (2838.85)

23,949.17^a,b (8213.34)